A detailed history of Banque Transatlantique Sa transactions in Pfizer Inc stock. As of the latest transaction made, Banque Transatlantique Sa holds 27,665 shares of PFE stock, worth $693,838. This represents 0.02% of its overall portfolio holdings.

Number of Shares
27,665
Previous 31,165 11.23%
Holding current value
$693,838
Previous $755,000 6.75%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$23.29 - $25.88 $81,515 - $90,580
-3,500 Reduced 11.23%
27,665 $704,000
Q2 2025

Aug 14, 2025

SELL
$21.59 - $24.84 $41.1 Million - $47.3 Million
-1,903,366 Reduced 98.39%
31,165 $755,000
Q1 2025

Sep 09, 2025

BUY
$25.01 - $27.13 $817,601 - $886,906
32,691 Added 104.9%
63,856 $1.61 Billion
Q1 2025

May 15, 2025

BUY
$25.01 - $27.13 $46.7 Million - $50.7 Million
1,867,525 Added 2787.1%
1,934,531 $49 Million
Q4 2024

Feb 14, 2025

BUY
$24.8 - $30.19 $1.66 Million - $2.02 Million
67,006 New
67,006 $1.77 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Banque Transatlantique Sa Portfolio

Follow Banque Transatlantique Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Transatlantique Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Transatlantique Sa with notifications on news.